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Abstract
Background: New approaches are needed for large-scale predictive modeling of cellular signaling networks. While
mass action and enzyme kinetic approaches require extensive biochemical data, current logic-based approaches
are used primarily for qualitative predictions and have lacked direct quantitative comparison with biochemical
models.
Results: We developed a logic-based differential equation modeling approach for cell signaling networks based on
normalized Hill activation/inhibition functions controlled by logical AND and OR operators to characterize signaling
crosstalk. Using this approach, we modeled the cardiac b1-adrenergic signaling network, including 36 reactions and
25 species. Direct comparison of this model to an extensively characterized and validated biochemical model of
the same network revealed that the new model gave reasonably accurate predictions of key network properties,
even with default parameters. Normalized Hill functions improved quantitative predictions of global functional
relationships compared with prior logic-based approaches. Comprehensive sensitivity analysis revealed the
significant role of PKA negative feedback on upstream signaling and the importance of phosphodiesterases as key
negative regulators of the network. The model was then extended to incorporate recently identified protein
interaction data involving integrin-mediated mechanotransduction.
Conclusions: The normalized-Hill differential equation modeling approach allows quantitative prediction of
network functional relationships and dynamics, even in systems with limited biochemical data.
Background
The b-adrenergic signaling pathway plays a key role in
the regulation of normal heart function and the develop-
ment of heart failure [1-5]. Systems analysis of b-
adrenergic signaling in the heart may provide important
new insights into the mechanisms of heart failure and
reveal new therapeutic targets. Previous mathematical
models of cardiac b-adrenergic signaling have character-
ized how biochemical mechanisms of this pathway
determine its coordinated regulation of cell contractility
in health and disease [6-8]. However, this work relied
on extensive biochemical data from the literature that
may not be available for more recently discovered path-
ways. Therefore, more scalable modeling approaches are
needed.
As an alternative to generating biochemically detailed
kinetic models, several modeling approaches that are
more closely based on network topology have been
developed including Boolean modeling [9], fuzzy logic
modeling [10] and extreme pathways analysis [11].
These approaches require few or no parameters and
facilitate large-scale analysis of systems properties, such
as feedback loops and feasible solution spaces. But these
approaches have a variety of limitations. While extreme
pathways analysis predicts the entire feasible steady-
state solution space of a network, its ability to predict
dynamic time-courses for given experiments is lim-
ited [12]. Simulations from discrete-level models (e.g.
Boolean) can be difficult to interpret due to sensitivity
of model predictions to temporal updating schemes
[13], assignment of discrete activity-levels to continu-
ous-valued variables like concentration [14], and the
limited ability to describe realistic timescales [15]. The
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ing approaches has recently been reviewed [16]. In addi-
tion, these modeling approaches are generally not
compatible with the wealth of systems analysis tools for
differential equations from control theory and dynamical
systems. Piecewise-linear differential equation models
overcome some of these limitations by making both spe-
cies values and time continuous, but steady-state species
activities are still binary [9,15,17]. Others have modeled
signaling networks with continuous approximations of
Boolean functions [18] that are implemented to mini-
mize steady-state differences between Boolean and con-
tinuous models.
To address these limitations, we developed a normal-
ized-Hill differential equation modeling approach that
combines advantages of both biochemical and Boolean
models. This approach uses normalized Hill functions
and logical AND and OR operators to describe network
crosstalk. We used this approach to model the cardiac
b-adrenergic signaling pathway and performed a direct
comparison with a previously validated biochemical
model of the same network [6,7]. We then used this
model to gain insight into the roles of feedback and
feed-forward loops in the b-adrenergic pathway and
examined potential crosstalk with integrin-mediated
mechanotransduction. The analysis presented here
demonstrates that the normalized-Hill differential equa-
tion modeling approach can provide reasonably accurate
predictions of signaling properties, even when little
parameter data is available.
Results
Toy signaling network
For demonstration, we created a toy signaling network
using our normalized-Hill differential equation
approach. This simple network consists of two input
ligands ("A” and “B”) that activate receptors “C” and
“D”, respectively. A positive feedback loop exists
between “C” and “E” that is inhibited when “D” is acti-
vated (see Figure 1A). The state variables represent the
“fractional activation” of the signaling species, which is
normalized to the maximal possible activity. Fractional
activation varies continuously with time and can take on
any value between 0 and 1, inclusive. For example, frac-
tional activation for a substrate that is active only when
phosphorylated is equivalent to the ratio of phosphory-
lated to total protein.
Model equations for this toy network are provided in
“Methods” and Additional File 1, Supplemental Methods,
though properties of our modeling approach are discussed
here. Interactions between species are modeled using nor-
malized Hill functions with 3 reaction parameters: the
reaction weight “W”, half-maximal effective concentration
“EC50“, and Hill coefficient “n”. The reaction weight
determines how much a given interaction activates or
inhibits an output species and can take on any value
between 0 and 1, inclusive. EC50 is the fractional activation
of an input species required to induce half-maximal activa-
tion of an output species. Lastly, the Hill coefficient deter-
mines sensitivity to changes in inputs. The normalized
Hill functions are constrained to f(0) = 0, f(1) = 1 and f
(EC50) = 0.5. Additionally, species activities are controlled
by the parameters τ and YMAX, which are the reaction
time constant and species maximal fractional activation,
respectively. While YMAX = 1 is typical, this value can be
altered to reflect a change in protein expression relative to
a reference condition. Typical default reaction and species
parameter values are W = 1, EC50 = 0.5, n = 1.4, τ =1 ,a n d
YMAX = 1; choice of default values for EC50 and n are
examined in more detail below. Crosstalk between species
is modeled using continuous functions analogous to Boo-
lean AND and OR operations (see Methods).
While default parameters can provide qualitatively rea-
sonable results, the parameters involved in these Hill func-
tions can be directly measured in cellular experiments to
Figure 1 Normalized-Hill toy network model.A )S c h e m a t i co f
the 5-species toy network, including two inputs, an AND reaction,
and a positive feedback loop. B) Characteristics of sample
normalized-Hill functions (n = 4 for both curves). C) Simulated
signaling dynamics in response to transient inputs A, B, and A + B.
Output E remains active after removal of input A due to a bistable
positive feedback loop, though this memory is erased with addition
of B. Addition of both stimuli at the same time transiently activates
output E. Parameters used are: τ = 1, W = 1, n = 1.4, and EC50 = 0.5.
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the toy model, WD,K B and nB could all be determined
directly from a single steady-state concentration
response where B is varied and D is measured. Like-
wise, τD could be determined experimentally by mea-
suring the dynamic response of D in response to a
step in B. If D is a kinase substrate, typical experi-
ments could include quantitative Western blots, cellu-
lar immunofluorescence, or live-cell FRET biosensors
similar to those used previously for measuring active
PKA dynamics in cardiac myocytes [19].
Figure 1C shows a sample simulation of toy network sig-
naling dynamics in response to a transient exposure to input
“A”,i n p u t“B”, followed by both inputs simultaneously. Note
that “C” and “E” retain full activity even after input “A” has
been removed due to the presence of a bistable positive feed-
back loop. However, this memory is erased once input “B” is
activated. When “A” and “B” are activated simultaneously,
“E” is transiently activated but switches off once precursors
“C” and “D” become highly active.
Because this modeling approach uses ordinary differ-
ential equations, well-established systems approaches,
such as quantitative sensitivity analysis, can be readily
applied to study network relationships. The sensitivity
plot shown in Figure 2 quantifies the global functional
relationships between all species in the system. Each col-
umn simulates an individual experiment in which the
maximum activity of one species is perturbed
(e.g. “AMAX“) and the subsequent changes in all network
species’ activities are quantified. The normalized
steady-state sensitivities of these species to parameter
perturbations are quantified according to S = (ΔY/ΔP)
(Po/Yo)( s e eMethods for details). Graded positive and
negative sensitivities are represented with shades of red
and green, respectively. For example, the “B” column
indicates that increased fractional activation of “B”
causes increased activity of itself and “D”, decreased
activity of “E” and (to a lesser extent) “C”, and no
change in the activity of “A”. This type of quantitative
sensitivity analysis is not possible with many other
logic-based or topological approaches.
b-adrenergic signaling network
We next applied our normalized-Hill modeling approach
to the cardiac b-adrenergic signaling network, the major
pathway that regulates contractility, metabolism, and
gene regulation of the heart [20]. Following stimulation
by b agonists (e.g. norepinephrine or NE), the b-adrener-
gic receptor couples with G proteins, which subsequently
activate adenylyl cyclase (AC). AC synthesizes the second
messenger cAMP, which causes dissociation of the regu-
latory and catalytic subunits of protein kinase A (PKAR
and PKAC, respectively). PKAC phosphorylates several
substrates, including phospholamban (PLB), the ryano-
dine receptor (RyR), troponin I (TnI), and inhibitor-1
(Inhib1), resulting in enhanced cardiac contractility. Fig-
ure 3 shows a schematic of this model, which includes 25
species and 36 reactions. All interactions were implemen-
ted using the same default parameters used in the toy sig-
naling network. Importantly, the network topology for
this normalized-Hill model was designed to be very simi-
lar to an extensively characterized and validated bio-
chemical model of this same network [7].
To test the normalized-hill b-adrenergic model, we
simulated a simple experiment in which NE is added to
the system and subsequently removed. The addition of
NE indirectly activates G proteins (Gsa), cAMP, and PLB
(Figure 4A). The response delay of cAMP and PLB to NE
(as compared to Gsa) occurs because these species are
farther downstream in the signaling cascade. An adaptive
response to the sustained NE input is observed in these
activation profiles, as seen experimentally for cAMP
[21,22], which may be attributed to the negative feedback
loops consisting of PKAC and GRK phosphorylation of
b1ARs (see below). Responses for individual species activ-
ities during simulations with varying levels of NE were
also evaluated; a sample dose response is shown in Figure
4B, where increased levels of NE produced concomitant
increases in the fractional activities of Gsa,c A M P ,a n d
PLB, as expected from experiments [23,24].
Role of feedback and forward loops in shaping network
dynamics
Feedback and feed-forward loops are key network motifs
that can enhance information processing by altering
Figure 2 Sensitivity analysis of the toy network: Each column of
the sensitivity matrix represents a numerical experiment in which
one species was perturbed by -25%. The steady-state sensitivities of
all model species were computed according to S = (ΔY/ΔP)(Po/Yo).
The model predicts that E is positively regulated by A and C but
negatively regulated by B and D.
Kraeutler et al. BMC Systems Biology 2010, 4:157
http://www.biomedcentral.com/1752-0509/4/157
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network, there are two negative feedback loops, both
involving receptor phosphorylation by either PKA or G-
protein receptor kinase (GRK), which desensitize the b-
adrenergic receptor to ligand inputs. Receptor desensitiza-
tion leads to an adaptive response to the ligand NE. For 4
PKA substrates (PLB, IKs, ICa, RyR) there are coherent
positive feed-forward loops formed when PKA enhances
substrate phosphorylation both directly (PKA phosphory-
lates the substrate) and indirectly by blocking inhibitor-1
(Inhib1), which phosphorylates protein phosphatase 1
(PP1), inhibiting substrate phosphorylation. We hypothe-
sized that these feedback and feed-forward loops contribu-
ted to the predicted adaptive dynamics seen in our default
simulations of PLB activity (see Figure 4A). To test this,
we performed simulations in which each of these feedback
or feed-forward loops were disrupted (i.e. setting their cor-
responding reactions weights, WGRK-B1ARPG,W PKAC-
B1ARPA,o rW PKAC-Inhib1, to zero) (Figure 5).
Surprisingly, disrupting individual loops had dramati-
cally different consequences. Inhibition of the GRK
negative feedback loop resulted in sustained oscillations,
indicating that GRK negative feedback contributed to
damping PLB phosphorylation. In contrast, inhibition of
the PKA negative feedback loop raised the steady-state
PLB activity and disrupted oscillations, showing that this
feedback loop controlled steady-state PLB adaptation.
Lastly, blocking the inhibitor-1 feed-forward loop
reduced PLB activity without qualitatively affecting the
timecourse, suggesting that this loop amplifies PLB sig-
naling. Previous experimental and modeling studies
comparing GRK and PKA feedback loops studied the
b2-AR isoform, where receptor desensitization was dri-
ven primarily by GRK [26,27]. However, steady-state
measurements in cells expressing b1-AR [28], the recep-
tor isoform considered here, are consistent with the cur-
rent model predictions that both GRK and PKA
feedbacks contribute significantly to PLB responses, via
b1-adrenergic receptor desensitization. Thus, the nor-
malized-Hill modeling approach can be used to assess
Figure 3 Schematic of normalized-Hill b-adrenergic signaling
network. The normalized-Hill model consists of 25 species and 36
reactions. While developed using a normalized-Hill differential
equation approach, the network topology closely mimics a well-
validated biochemical model [6] to allow for direct comparisons.
Figure 4 Predicted dynamics and dose responses of the
normalized-Hill b-adrenergic model. A) Predicted dynamics of G
proteins (Gsa), cyclic AMP (cAMP), and phospholamban (PLB)
phosphorylation in response to a transient norepinephrine (NE)
exposure (NE = 1). B) Steady-state concentration responses of Gsa,
cAMP and PLB to varying levels of NE.
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dynamics, though results can be refined when experi-
mental data is available (discussed further in subsequent
sections).
Quantitative sensitivity analysis of the b-adrenergic
network
Quantitative sensitivity analysis provides an approach to
systematically survey the functional relationships within
a signaling network, often revealing unexpected systems
properties. We performed sensitivity analysis on our
normalized-Hill b-adrenergic model using the same
approach as that implemented for our toy network (Fig-
ure 6A). For this analysis, model inputs were set at
moderate activity levels to avoid saturation of the net-
work’s dynamic range (NE = 0.5, Fsk = 0.2, IBMX =
0.2). Species are generally ordered from upstream (top/
left) to downstream (bottom/right) in the sensitivity
matrix. From this analysis, sev e r a lg l o b a lp r o p e r t i e so f
the network can be identified. The diagonal represents
self-activation, which is not always prominent due to
the negative feedback loops discussed earlier. While
upstream species in the left portion of the matrix (NE
through PKAC) affect many others, species further
downstream in the pathway (PP2A through PP1) affect
fewer. This indicates that the downstream species are in
Figure 5 Dynamic roles for feedback and feed-forward loops in
the b-adrenergic network. Time courses of PLB activation in
response to transient NE exposures (NE = 1) with several network
perturbations. The thick solid line is the response of the default
model, showing moderate PLB activation and damped oscillations.
Also shown are simulations in which either the inhibitor-1 coherent
positive feed-forward loop (thick dashed line; WPKAC-Inhib1 = 0), the
GRK negative feedback loop (thin dashed line; WGRK-B1ARPG =0 )o r
the PKAC negative feedback loop (thin solid line; WPKAC-B1ARPA =0 )
were eliminated. Inhibitor-1 amplified PLB activation without
affecting PLB dynamics. Both GRK and PKAC feedback loops
decreased PLB phosphorylation via b1-adrenergic receptor
desensitization, though PKAC controlled steady-state adaptation
while GRK feedback dampened the PLB response.
Figure 6 Sensitivity analysis of the b-adrenergic network
identifies key system regulators. A) Sensitivity analysis of the
normalized-Hill b-adrenergic model. Note the bright green squares
prevalent in the phosphodiesterase (PDE), protein kinase inhibitor
(PKI), and phosphatase 2A (PP2A) columns, implicating the
importance of these three species as key negative regulators of the
system. B) Sensitivity analysis of a detailed biochemical model of the
same pathway, allowing for direct comparison of the two modeling
approaches. A Pearson correlation coefficient of 0.75 was computed
between the individual sensitivities of the two models,
demonstrating substantial quantitative agreement between the
functional outputs of the two modeled networks.
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back on upstream components.
Importantly, this analysis reveals quantitative relation-
s h i p st h a ta r en o ta p p a r e n tf r o mt h en e t w o r kt o p o l o g y
alone. Several inhibiting (green) relationships, mainly
involving PDE, PKI, and PP2A, are quantitatively promi-
nent. These proteins appear to be key negative regula-
tors of this network that may serve as potential
therapeutic targets. PDE strongly inhibits (green) PKAC,
TnI and B1ARPA, while it modestly activates B1AR and
AC. These effects are not explained completely by path
length, as PDE has a smaller effect on its direct target
(cAMP) than species which are three steps away (e.g.
TnI, B1ARPA). Indeed, the PDE inhibitor milrinone has
been used for patients with congestive heart failure [29].
However, milrinone actually worsens mortality by ele-
vating occurrences of ventricular arrhythmias [30,31],
perhaps due to the large number of PDE-sensitive spe-
cies suggested by our modeling results. PP2A is a strong
inhibitor of TnI with less strong inhibition of IKs and
PLB. In contrast, other perturbations such as Fsk and
IBMX exhibit rather modest effects on the network
despite affecting many other species in a qualitative
sense.
Examining a particular row in this matrix allows one
to identify perturbations that are more or less likely to
affect a given output. For example, the calcium channel
ICa appears very sensitive to activation by cAMP or
inhibition by PDE, but is less sensitive to Fsk activation
(same path length as PDE) or direct PP1 inhibition.
Some species have low quantitative sensitivity even
though they are within the same pathway. For example,
direct substrates of PKAC (e.g. b1ARPA, ICa, PLB) are
highly sensitive to perturbations in AC, cAMP and
PKAC, while other species in the same pathway, such as
b1AR or Gsa, are much less sensitive. Many of these
quantitative predictions cannot be achieved by qualita-
tive graph analysis, and may be used to prioritize future
experiments.
Direct comparison of normalized-Hill and biochemical
models
In order to assess the predictive accuracy of the normal-
ized-Hill b-adrenergic model, the model’s sensitivity
matrix was compared to a similar matrix generated
from a detailed biochemical model of the same signaling
network [7] (Figure 6B, additional details in Methods).
The difference between these two matrices is shown in
Figure 6C. Overall, there are a number of similarities
between the structures of the two sensitivity matrices.
Note the clear divisions between upstream and down-
stream components, indicating similar predictions of
global functional relationships across the two models.
To quantify these similarities, we computed the Pearson
correlation coefficient between the corresponding sensi-
tivities of the two models and obtained a value of 0.75.
This analysis indicates that there is substantial quantita-
tive agreement between the two models, considering the
significant differences in their formulation and the use
of default parameters in the normalized-Hill model.
To test the appropriateness of our default selections
for Hill coefficients and EC50 values, we examined cor-
relation coefficients between the biochemical model and
normalized-Hill models while varying default “n” and
EC50. We found that the predictions were insensitive to
the choice of default Hill coefficient (though n = 1.4
was optimal), but highly sensitive to the intuitive EC50
value of 0.5. Higher sensitivity to EC-50 arises because a
linear pathway tends to systematically amplify or dimin-
ish signals when default EC-50 deviates from 0.5 (see
Additional File 2, Figure S1).
Despite striking similarities between predictions by the
normalized-Hill and biochemical models, there are also
several notable discrepancies that may provide further
insight. To highlight these, we re-classified the predicted
sensitivities from both models as either “activating” (S =
1), “inhibiting” (S = -1), or “neutral” (S = 0) and pro-
duced qualitative sensitivity matrices using only these
values (see Additional File 3, Figure S2, additional
details in Methods). Globally, the two models showed
good agreement in terms of individual sensitivity types,
with 457 out of 484 (94%) individual sensitivities quali-
tatively matching. Of the 27 mismatches, 3 of these
were in opposite directions (0.62% of the total). This
was seen, for example, when Gsa/bg (GsaBg) was per-
turbed: the normalized-Hill model predicted that reduc-
tion of Gsa/bg increases activation of B1AR and
B1ARPG, while the opposite result was obtained from
biochemical model predictions. In the normalized-Hill
model, reduced PKA feedback via reduced GsaBg
enhanced fractional activation of B1AR and, thus,
B1ARPG. These results are expected given that all nor-
malized-Hill model interactions are unidirectional. On
the other hand, the biochemical model uses detailed
mass action kinetics to describe these interactions,
where a reduction in total Gsa/bg can actually pull
additional free receptors to a bound form, resulting in
reduced B1AR and B1ARPG. Thus, there are competing
mechanisms in this portion of the network (PKA feed-
back versus G-protein activation) that are represented
differently between the two model types. Related to this
issue, most species in the biochemical network are sen-
sitive to perturbations in Gbg, though to a very small
extent quantitatively (compare Gbg columns in Figures
6B and S2). This subtle difference arises because Gbg is
a terminal node in the normalized-Hill model, whereas
the additional details of the biochemical model
allow Gbg perturbations to very modestly influence
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cant in most cases, these results highlight subtle limita-
tions in the normalized-Hill b-adrenergic signaling
model that can be addressed with additional reactions
(though not done here).
Other discrepancies are attributed to differences in the
extent to which spatial compartmentation was incorpo-
rated in the two models. For example, all downstream
PKA substrates are sensitive to inhibitor-1 perturbation
in the normalized-Hill model since this species inhibits
global PP1 activity. In the biochemical model, however,
inhibitor-1 is only responsible for local inhibition of PP1
near PLB (but not other PKA substrates; see Inhib1 col-
umns in Figure 6). Thus, many of the discrepancies can
be attributed to subtle differences in network connectiv-
ity rather than the modeling approaches themselves.
Other logic-based modeling approaches have also used
logical AND/OR interactions and differential equations
to describe biochemical networks [9,15,18]. While these
logic-based approaches have not previously been directly
compared to a biochemical model, we extended the sen-
sitivity analysis (as in Figure 6) to examine these
approaches as well. The b-adrenergic model was re-
implemented using piece-wise linear, Hill, or linear acti-
vation functions. As shown in Additional File 4, Figure
S3 and Additional File 5, Figure S4, the normalized-Hill
approach exhibits substantially better performance com-
pared with the piece-wise linear approach or Hill equa-
tions with previously-used default parameters (n = 3,
K = 0.3) [18]. The poor performance of the piece-wise
linear approach is largely due to the fact that its steady-
state values are restricted, hindering predictions of sen-
sitivity to a quantitative perturbation. The Hill approach
performed poorly as well, but its performance could be
improved somewhat by optimizing parameters “n” and
“K”. Linear activation functions worked fairly well for
this steady-state sensitivity analysis, but linear activation
functions are not able to predict nonlinear phenomena
such as the bistability shown in Figure 1.
To further compare predictions from the normalized-
Hill and biochemical models, we examined the predicted
dynamics of Gsa and PLB in response to a transient NE
exposure. Though global functional relationships are
strikingly similar between the two models (Figure 6), the
normalized-Hill model outputs using all default para-
meters contains damped oscillations that are not promi-
nent in the biochemical model (compare Figure 4A with
the left panel in Figure 7). To test whether the normal-
ized-Hill model predictions can be refined further, we fit
several parameters in the normalized-Hill model to
time-course data from the biochemical model using a
nonlinear least squares optimization algorithm (lsqnon-
l i ni nM a t l a b ) .E l e v e np a r a m e t e r s( 4τ’s, 3 weights,
3E C 50’s, and an additional basal receptor activity term)
were adjusted to fit model predictions (see Additional
file 1, Supplemental Methods).
These parameter adjustments allowed for more similar
signaling dynamics and comparable peak fractional
activities of Gsa and PLB compared with the biochem-
ical model (Figure 7), with more gradual adaptation
rather than damped oscillations. We further probed
whether conclusions drawn regarding the feedforward
and feedback loops from Figure 5 would be maintained
in the adjusted model. As shown in Additional File 6,
Figure S5, while the PLB response exhibits gradual
adaptation rather than damped oscillations, the role of
the feedforward and feedback loops are similar: Inhibitor
1 amplifies PLB, B1ARPG attenuates PLB, and B1ARPA
dominates the degree of steady-state adaptation. These
analyses demonstrate that the normalized-Hill model
largely captures key features of the more detailed bio-
chemical model, that specific model discrepancies can
be quantitatively explained by parameter differences,
and that dynamic predictions can be refined by fitting
relevant parameters to available data.
Model extension to incorporate integrin-mediated
mechanotransduction
Due to the wealth of data needed to parameterize a bio-
chemical model, it can be difficult to extend the model
with new experimental findings. However, the normal-
ized-Hill modeling framework may be more easily
extended. We searched the Pathway Commons database
http://www.pathwaycommons.org/pc/ for additional
PKA substrates, finding 46 pathways and 63 catalysis
Figure 7 Comparing predicted dynamics of the normalized-Hill
model with a detailed biochemical model. The left panel shows
normalized dynamic responses of Gsa and PLB phosphorylation
predicted by the biochemical model during a transient 10 nM NE
exposure. Normalized-Hill model predictions of the same outputs
during a similar NE exposure are shown in the right panel. Activity
levels and dynamics of the normalized-Hill model traces were fit to
those of the biochemical model via least-squares parameter
estimation. In all, 11 parameters were adjusted (4 τ’s, 3 W’s, 3 EC50’s,
and an additional basal receptor activity term) to mimic biochemical
model outputs using the normalized-Hill model.
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phosphorylation of b-integrins, which regulates cellular
adhesion [32]. Alenghat et al. recently showed that
shear stresses applied to b1 integrins using RGD-coated
magnetic microbeads stimulated cAMP via Gsa [33]. By
integrating this new data into our model, we predicted
that mechanical stresses may activate the cAMP/PKA
pathway in cardiac myocytes in a manner independent
of b-adrenergic receptors. Additional File 7, Figure S6
shows how these mechanisms were incorporated into
the normalized-Hill model. We ran a simulation in
which only mechanical stress was applied to the net-
work (i.e. NE = Fsk = IBMX = 0), and saw activation of
Gsa, cAMP, and integrin b-subunit phosphorylation
(Itgbp) (Figure 8). Note that the response times of these
outputs to the stress stimulus are dependent on their
relative positions in the signaling cascade. As an inde-
pendent validation of these predictions, prior work has
shown that stretch of intact heart induces a rise in
cAMP, which may contribute to stretch-induced
increases in cardiac contractility [34].
Discussion and conclusions
We developed a normalized-Hill differential equation
modeling approach that combines advantages of both
biochemical and Boolean models. Even when parameters
are not available, this approach allows for predictions of
signaling dynamics and is compatible with a wide range
of existing systems analyses, including quantitative sensi-
tivity analysis. Furthermore, these models can be itera-
tively refined by either tuning parameter values (as done
here) or adding additional reactions to better reflect
quantitative features of experimental data. This
approach was evaluated by direct quantitative compari-
son with a well characterized and experimentally vali-
dated biochemical model of the cardiac b-adrenergic
signaling network [7].
The analysis revealed several new insights into rela-
tionships between b-adrenergic network topology and
dynamics. Dissection of the feedforward and feedback
loops showed that each loop could play a unique role in
regulating PLB phosphorylation dynamics. The Inhibi-
tor-1-mediated coherent positive feedforward loop was
predicted to amplify signaling, which is consistent with
reports of decreased PLB phosphorylation in mice with
Inhibitor-1 ablation [35]. In contrast, PKA- and GRK-
mediated negative feedback loops (B1ARPA and
B1ARPG, respectively) reduced PLB phosphorylation
either by enhancing steady-state adaptation (PKA) or
attenuating the overall PLB signal (GRK). While the
kinetics and damped oscillations were sensitive to the
rate constants for these feedback loops, the overall roles
of the feedback loops were maintained using both
default and adjusted parameters in the normalized-Hill
model. Quantitative sensitivity analysis revealed the glo-
bal structure of functional relationships in this network,
which was not clear from previous analyses of the bio-
chemical model [6]. This suggests that therapeutically
targeting species within the PKA negative feedback loop
may be less specific than targeting individual branches
involving PKA substrates. Sensitivity analysis highlighted
key hubs (such as PDE’s) as major inhibitors of this
pathway, consistent with drug development in this area
[36]. Sensitivity analysis also revealed quantitative rela-
tionships that are not seen from the topology alone,
such as lower sensitivity of Gsa and AC to perturba-
tions in PKAC. Finally, model extension allowed analysis
of crosstalk with integrin-mediated mechanotransduc-
tion, helping to explain experimentally-observed cAMP
synthesis and increased cardiac contractility during
stretch [34].
The normalized-Hill differential equation approach is
related to logic-based approaches that also attempt to
simulate biological networks with limited parameter
data. The most well-characterized qualitative approach
is Boolean network modeling, where species states are
binary and the network is simulated over discrete time
[37]. The binary state limitation can be partially over-
come by allowing multiple discrete states [38], but this
requires additional information to determine the num-
ber of states and to what state a given reaction activates
a species. Discrete-time models can also require com-
plex updating schemes to avoid artifacts [15], resulting
in stochastic simulation data that increases the complex-
ity of subsequent analysis. To address these issues,
Figure 8 Model extension to include integrin activation and
phosphorylation in response to mechanical stress. Reactions for
stress-induced integrin activation and subsequent phosphorylation
by PKA were identified from recent protein interaction data http://
www.pathwaycommons.org/pc/. Shown are predicted dynamics
during a transient mechanical stress stimulus for Gsa (which is
stimulated by the stress input), cAMP, and integrin phosphorylation
(Itgbp) by PKA. The mechanisms for this additional pathway are
schematized in Additional File 7, Figure S6.
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oped, which allow continuous-valued species states and
continuous time [9,15,17]. Like our approach, piecewise
linear differential equations use logical AND/OR opera-
tions and represent time-dependence with differential
equations. However, this approach still uses discrete
thresholds for activation of reactions that may not be
consistent with experimental data, and the steady-state
predictions of these models a r eb i n a r y[ 3 9 ] .A sar e s u l t
of limited possible steady-state values, we found that
piecewise linear differential equations could not accu-
rately predict quantitative model sensitivities. However,
an advantage of the piecewise linear approach is that it
requires fewer parameters: time constants and activation
threshold parameters.
A so p p o s e dt od i s c r e t et h r e s h o l d s ,aw i d ev a r i e t yo f
biological networks exhibit smoothly saturating activa-
tion profiles that are well-approximated by Hill func-
tions. Hill functions have been used to model a wide
range of phenomena, including hemoglobin binding
[40], dynamics of synthetic gene networks [41] and sig-
naling pathways [42]. Because our state variables are
generally limited to values between 0 and 1, we devel-
oped a normalization scheme that constrained activating
Hill functions such that f(0) = 0, f(1) = 1 and f(EC50)=
0.5. We found that normalizing with just 2 of these 3
constraints, as done previously [18], caused undesirable
shifts in EC50’s or maximal activities, resulting in either
diminished or enhanced signaling down a linear path-
way. These artifacts limited the dynamic range of the
pathway and hindered quantitative sensitivity analysis as
compared with the biochemical model. In addition, we
have included parameters that allow for further quanti-
tative refinement of model predictions: reaction weights
(W) and maximum activity values (YMAX). Reaction
weights allow certain reactions to exert more influence
than others. This was important for refinement of our
b-adrenergic model because only partial receptor desen-
sitization is seen experimentally [22]. Ability to perturb
YMAX values was critical for performing quantitative
sensitivity analysis in the present work, but this also
allows for future incorporation of changes in protein
expression that are independent of the level of fractional
activation.
Direct quantitative comparison of the normalized-Hill
b-adrenergic model with a validated biochemical model
allowed characterization of the strengths and weaknesses
of this approach in a controlled environment. To our
knowledge, such a direct comparison has not been pre-
viously made for other logic-based approaches. Through
sensitivity analysis and time course comparisons, we
found that default parameter values were sufficient to
predict global functional relationships with relatively
high quantitative agreement, especially in terms of
responses to systematic perturbations (correlation coeffi-
cient of 0.75). Indeed, the vast majority of experimental
data on signaling networks provides relative rather than
absolute quantification [43]. The normalized-Hill activa-
tion function outperformed piecewise linear, Hill and
linear activation functions. Absolute quantitative predic-
tions of particular time constants or signal magnitudes
can be achieved with either prior parameter knowledge
or optimization-based parameter estimation. Because
only a small number of steps in a pathway are highly
sensitive or rate-limiting, high quantitative agreement
was obtained when fitting 11 parameters. By compari-
son, the biochemical model contains 88 parameters.
Because the model is composed of differential equa-
tions, this modeling framework is compatible with the
wealth of analysis tools currently available from dynami-
cal systems including sensitivity analysis (shown here),
bifurcation analysis [44] and parameter estimation (per-
formed in specific cases here) [45]. These models may
also be directly integrated with multi-scale models of
electrical-mechanical coupling or other aspects of phy-
siology [46].
A number of differences from biochemical models
must be considered regarding model structure. First,
species states are quantified in terms of fractional activa-
tion rather than absolute quantities such as concentra-
tion. While this may be appropriate for proteins where
the data is often normalized and the focus is on post-
translational modifications, small molecules such as cyc-
lic AMP are always in an “active” form. For such cases,
fractional activation may be considered to be relative to
the amount measured under a highly-stimulated condi-
tion. Second, not all relationships are well-represented
by activating or inhibiting Hill functions. Other activa-
tion functions can be used as appropriate, and the use
of differential equations allows a detailed biochemical
module to be easily embedded within a larger normal-
ized-Hill model or vice versa. Third, this normalized-
Hill approach does not explicitly incorporate competi-
tive inhibition, leading to a small number of incorrect
predictions when Gbg w a sp e r t u r b e d .F i n a l l y ,m u l t i p l e
post-translational modifications on a single protein may
be required to be represented as separate species, as we
have done for the GRK and PKA phosphorylation sites
on the b-adrenergic receptor (B1ARPG and B1ARPA,
respectively).
Despite these limitations, the normalized-Hill differen-
tial equation modeling approach predicts quantitative
systems properties that typically require detailed bio-
chemical models. Using default parameters, we obtained
accurate simulations of the b-adrenergic signaling net-
work that revealed unexpected functional relationships,
generated experimentally testable predictions and readily
incorporated new parameter and reaction data.
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scale reconstruction and analysis of signaling networks,
particularly for those where biochemical characterization
is limited.
Methods
Normalized-Hill differential equation modeling approach
Species dynamics are predicted using ordinary differen-
tial equations, where the state variables represent frac-
tional activation of each species. Species interactions
were defined with normalized activating or inhibiting
Hill functions (fact or finhib) which are described below.
Pathway crosstalk was implemented using logical AND
and OR operations: “f(x)f(y)” and “f(x)+f(y)-f(x)f(y)”,
respectively. Using this approach, the toy model
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where τ is the time constant for a given species, W is
the reaction weight (constrained to 0≤W≤1), and YMAX
is the maximal fractional activation allowing simulations
of knock-down (YMAX < 1) or overexpression (YMAX >
1). The normalized activating or inhibiting Hill func-
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We further constrained fact(X) = 1 for X≥1t oe n s u r e
that species activities are limited to YMAX. As default
parameters, we used W = 1, EC50 =0 . 5 ,n=1 . 4 ,τ =1 ,
and YMAX = 1. Sensitivity of b-adrenergic model predic-
tions to the choice of default values for n and EC50
were examined (see Additional File 2, Figure S1). The
model was insensitive to the default Hill coefficient,
with Pearson correlation coefficients ≥ 0.93 for 1.01 ≤ n
≤1.7 compared to n = 1.4. Sensitivity to default EC50
was higher because a value other than 0.5 causes a lin-
ear pathway to systematically amplify or diminish signal-
ing at subsequent steps. All differential equations were
implemented in MATLAB (MathWorks, Natwick MA)
and solved numerically with the ode23 function.
Sensitivity analysis
Two-dimensional sensitivity matrices were generated
from normalized-Hill model simulations according to
the equation Sij =( ΔYi/ΔPj)(Po,j/Yo,i), where Sij is the
sensitivity of species “i” to perturbation of species “j”,
ΔYi is the change in steady-state output of species “i”,
and ΔPj is the change in parameter “j”. These sensitiv-
ities are normalized to the original output (Yo,i)a n d
parameter value (Po,j) to facilitate comparison between
parameters and species. For a given numerical experi-
ment (i.e. a column in a sensitivity matrix), a single spe-
cies’ YMAX was perturbed by ΔP (in general, -25%). The
model was run to steady state and the normalized sensi-
tivities in all model species (rows of the sensitivity
matrix) were computed. Thus, the sensitivity matrix
represents a total of ni*nj predictions from nj numerical
experiments. We found that different perturbation mag-
nitudes (-10 to -75%) produced very similar sensitivity
matrices (correlation coefficient > 0.98).
Comparison of normalized-Hill model with biochemical
model
Normalized-Hill model predictions were compared to
our previously described biochemical model [7] in terms
of parameter sensitivities and activation dynamics. Sensi-
tivity analysis was computed as described for the nor-
malized-Hill model, except that the biochemical model
does not incorporate YMAX parameters. Therefore, the
most analogous parameters were perturbed: total species
concentrations (where explicitly defined) or catalytic
rate constants associated with production of a particular
output. Biochemical model outputs were also selected to
be consistent with the normalized-Hill model species as
closely as possible. For quantitative comparison of nor-
malized-Hill and biochemical model sensitivity matrices,
a Pearson correlation coefficient was calculated from the
individual elements of the sensitivity matrices. For a
more qualitative comparison of the two models, we clas-
sified individual elements of the sensitivity matrix as
either “activating” (S = 1), “inhibiting” (S = -1) or “neu-
tral” (S = 0), in which threshold sensitivities of ±0.003
(determined by visual inspection of the histograms of
individual sensitivities from the two models) were used
to reassign individual values. Comparison of normal-
ized-Hill and biochemical models was performed by
counting the number of qualitatively matching indivi-
dual sensitivities and dividing by the total number of
matrix elements.
Biochemical model activation time courses were
performed in similar fashion to normalized-Hill
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Page 11 of 13simulations. Reported values are normalized to the max-
imal activation level for that particular output (e.g. con-
centration of phosphorylated PLB subunits over total
PLB). Ligand concentration was set to 10 nM where
‘NE’ is labeled in figures depicting biochemical model
outputs.
In some simulations (Figure 7), normalized-Hill model
parameters were adjusted to match outputs from the
biochemical model. A list of all adjusted parameters is
provided in Additional file 1, Supplemental Methods,
although the fitting procedure is described here. Time
courses for Gsa and PLB phosphorylation were obtained
from the biochemical model during a transient NE
exposure and normalized to their maximum values (i.e.
phosphorylated PLB over total PLB protein). Parameters
in the normalized-Hill model were then optimized using
nonlinear least-squares minimization (lsqnonlin in
MATLAB). This function adjusts selected parameter
values to minimize the sum of square errors between
data points; in this case, errors between normalized-Hill
and the normalized biochemical model predictions were
minimized. Several rounds of fitting with randomized
initial parameter guesses, along with some manual
adjustments, produced the final set of parameters used
to generate the normalized-Hill model curves in Figure
7. See Additional File 1, Supplemental Methods for
further details.
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Additional material
Additional file 1: Supplemental Methods. Model equations and
description of parameter estimation methods.
Additional file 2: Figure S1: Dependence of model accuracy on
choices for default parameters. A) Varying the choice of default Hill
coefficient has little effect on the predictive capability of the normalized-
Hill model compared to the detailed biochemical model, though n = 1.4
is optimal. B) Strength of normalized-Hill predictions are very sensitive to
the choice of default EC50, where model predictions dramatically
worsened as default EC50 deviated from the intuitive value of 0.5.
Additional file 3: Figure S2: Qualitative comparison of sensitivity
matrices from normalized-Hill and biochemical b-adrenergic
models. A) Individual elements of each sensitivity matrix were re-
classified as “activating” (red), “inhibiting” (green) or “neutral” (black), in
which a threshold sensitivity of +/- 0.003 was determined by visual
inspection of a histogram of sensitivities for each model. B) Difference
plot showing regions of qualitative discrepancy between normalized-Hill
model and the biochemical model. Globally, the two models showed
good agreement in terms of individual sensitivity types, with 457 out of
484 (94%) individual sensitivities qualitatively matching. Of the 27
mismatches, only 3 sensitivities were in opposite directions (difference of
-2; 0.62% of the total, see main text for further details).
Additional file 4: Figure S3: Comparison of biochemical model with
normalized-Hill model and alternative modeling implementations.
Differential equation models of the same b-adrenergic network were
generated using linear, piece-wise linear, or traditional Hill activation
functions. All other parts of the model were kept constant, including
time constants, reaction weights, AND/OR logic, and network topology.
A) Pearson correlation coefficients were computed by comparing the
sensitivity matrix of each model against the sensitivity matrix of the
biochemical model. The normalized-Hill approach produces the highest
level of agreement. B, left) Sensitivity matrix using Hill activation
functions of n = 3 and EC50 = 0.3, as used previously for default
parameters a for T-cell signaling network [17]. B, right) Difference
between the sensitivity matrices from the traditional Hill model (n = 3,
EC50 = 0.3) and the biochemical model, indicating areas of discrepancy.
Sensitivity matrices for remaining modeling approaches are shown in
Additional File 5, Figure S4.
Additional file 5: Figure S4: Sensitivity matrices and differences
from the biochemical model for b-adrenergic models implemented
with “piece-wise linear”, Hill, and linear activation functions.A )
Traditional Hill activation with n = 2 and EC50 = 0.5. B) Activation was
implemented as fact(x < 0.5) = 0, fact(x≥0.5) = 1 as described for “piece-
wise linear differential equations” in [9,15]. White indicates values with no
Real solution (NaN), which were excluded from computation of the
correlation coefficient. The poor agreement is related to the limited
number of possible steady-state values using this activation function. C)
Linear activation functions, implemented as fact(x) = x.
Additional file 6: Figure S5: Dynamic roles for feedback and feed-
forward loops in the b-adrenergic network in the adjusted
normalized-Hill Model. Using the adjusted model described in Figure 7,
perturbations to feedback and feed-forward loops were performed as in
Figure 5. The thick solid line is the response of the adjusted model to
transient NE exposure, showing moderate PLB activation and partial
adaptation to constant input. Also shown are simulations in which either
the inhibitor-1 coherent positive feed-forward loop (thick dashed line;
WPKAC-Inhib1 = 0), the GRK negative feedback loop (thin dashed line;
WGRK-B1ARPG = 0) or the PKAC negative feedback loop (thin solid line;
WPKAC-B1ARPA = 0) were eliminated. Inhibitor-1 amplified PLB activation
without affecting PLB dynamics. Both GRK and PKAC feedback loops
decreased PLB phosphorylation via b1-adrenergic receptor
desensitization, though PKAC controlled steady-state adaptation while
GRK feedback attenuated the PLB response. While the adjusted model
does not exhibit the damped PLB oscillations of the default model
(Figure 5), the roles of these feed-forward and feedback loops were
largely maintained.
Additional file 7: Figure S6: Schematic of the b-adrenergic network
with addition of integrin signaling. Based on recent protein
interaction data http://www.pathwaycommons.org/pc/, reactions
involving mechanical stress, RGD-coupled microbeads, integrins (Itg), and
PKA-mediated integrin phosphorylation (Itgbp) were added to the model
to demonstrate the extensibility of the normalized-Hill modeling
approach.
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